Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2026-04-16 @ 2:17 PM
Study NCT ID:
NCT02536859
Status:
COMPLETED
Last Update Posted:
2019-05-01
First Post:
2015-08-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08-31
Start Date Type:
ACTUAL
Primary Completion Date:
2016-04-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-14
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-28
First Submit QC Date:
None
Study First Post Date:
2015-09-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-30
Last Update Post Date:
2019-05-01
Last Update Post Date Type:
ACTUAL